SCOPUS 정보 검색 플랫폼

Volumn 18, Issue 100, 2009, Pages 55-

Rimonabant: Marketing authorisation suspended... at last! Withdrawal. Half-measures

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876437232 PISSN: 11677422 EISSN: None Source Type: Journal
DOI: None Document Type: Short Survey

Times cited : (3)

References (6)

1
- 70449692786
- EMEA - CHMP 23 October
- EMEA - CHMP "Press release. The European medicines agency recommends suspension of the marketing authorisation of Acomplia" 23 October 2008: 2 pages.
- (2008) Press Release. The European Medicines Agency Recommends Suspension of the Marketing Authorisation of Acomplia , pp. 2

2
- 84876455606
- Afssaps 23 October
- Afssaps "Communiqué de presse. Acomplia: suspension de l'autorisation de mise sur le marché" 23 October 2008: 2 pages.
- (2008) Communiqué de Presse. Acomplia: Suspension de l'Autorisation de Mise Sur Le Marché , pp. 2

3
- 33746417528
- Rimonabant
- Prescrire Editorial Staff
- Prescrire Editorial Staff "Rimonabant" Prescrire Int 2006; 15 (84): 123-126.
- (2006) Prescrire Int , vol.15 , Issue.84 , pp. 123-126

4
- 38449086276
- Rimonabant: Suicide and depression
- Prescrire Editorial Staff
- Prescrire Editorial Staff "Rimonabant: suicide and depression" Prescrire Int 2007; 16 (92): 250-251.
- (2007) Prescrire Int , vol.16 , Issue.92 , pp. 250-251

5
- 64249123222
- Gros bluff
- Prescrire Rédaction
- Prescrire Rédaction "Gros bluff" Rev Prescrire 2006; 26 (273): 401.
- (2006) Rev Prescrire , vol.26 , Issue.273 , pp. 401

6
- 20344382486
- How to avoid future Vioxx°-like scandal
- Prescrire Editorial Staff
- Prescrire Editorial Staff "How to avoid future Vioxx°-like scandal" Prescrire Int 2005; 14 (77): 115-117.
- (2005) Prescrire Int , vol.14 , Issue.77 , pp. 115-117

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.